Infilbray FDA Approval: Sanofi Pill Is First to Treat Brain Symptoms of Type 3 Gaucher Disease
The FDA approved Sanofi’s Infilbray (venglustat), the first drug for neurological symptoms of type 3 Gaucher disease, after it beat enzyme therapy in the LEAP2MONO trial.
